{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T08:56:56Z","timestamp":1783587416621,"version":"3.55.0"},"reference-count":86,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011624","name":"Marshfield Clinic Research Foundation","doi-asserted-by":"publisher","award":["AWD00025284 AGR 11\/09\/11"],"award-info":[{"award-number":["AWD00025284 AGR 11\/09\/11"]}],"id":[{"id":"10.13039\/100011624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders and affects approximately 4% of the global population. The diagnosis of IBS can be made based on symptoms using the validated Rome criteria and ruling out commonly occurring organic diseases. Although biomarkers exist for \u201cIBS mimickers\u201d such as celiac disease and inflammatory bowel disease (IBD), no such test exists for IBS. DNA microarrays of colonic tissue have been used to identify disease-associated variants in other gastrointestinal (GI) disorders. In this study, our objective was to identify biomarkers and unique gene expression patterns that may define the pathological state of IBS. Mucosal tissue samples were collected from the sigmoid colon of 29 participants (11 IBS and 18 healthy controls). DNA microarray analysis was used to assess gene expression profiling. Extraction and purification of RNA were then performed and used to synthesize cDNA. Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) was employed to identify differentially expressed genes in patients diagnosed with IBS compared to healthy, non-IBS patient-derived cDNA. Additional testing probed vitamin D-mediated regulation of select genes associated with serotonergic metabolism. DNA microarray analyses led to the identification of 858 differentially expressed genes that may characterize the IBS pathological state. After screening a series of genes using a combination of gene ontological analysis and RT-qPCR, this spectrum of potential IBS biomarkers was narrowed to 23 genes, some of which are regulated by vitamin D. Seven putative IBS biomarkers, including genes involved in serotonin metabolism, were identified. This work further supports the hypothesis that IBS pathophysiology is evident within the human transcriptome and that vitamin D modulates differential expression of genes in IBS patients. This suggests that IBS pathophysiology may also involve vitamin D deficiency and\/or an irregularity in serotonin metabolism.<\/jats:p>","DOI":"10.1371\/journal.pone.0275683","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T18:17:30Z","timestamp":1666289850000},"page":"e0275683","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Identification of putative transcriptomic biomarkers in irritable bowel syndrome (IBS): Differential gene expression and regulation of TPH1 and SERT by vitamin D"],"prefix":"10.1371","volume":"17","author":[{"given":"Aleksandra","family":"Grozi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keaton","family":"Coker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3352-3708","authenticated-orcid":true,"given":"Christopher M.","family":"Dussik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marya S.","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhela","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6481-9590","authenticated-orcid":true,"given":"Jin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Yale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Hockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6590-3791","authenticated-orcid":true,"given":"Tisha N.","family":"Lunsford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd R.","family":"Sandrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4950-9161","authenticated-orcid":true,"given":"Peter W.","family":"Jurutka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"issue":"1","key":"pone.0275683.ref001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2020.04.014","article-title":"Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study","volume":"160","author":"AD Sperber","year":"2021","journal-title":"Gastroenterology"},{"issue":"9","key":"pone.0275683.ref002","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/jama.2015.0954","article-title":"Irritable bowel syndrome: a clinical review","volume":"313","author":"WD Chey","year":"2015","journal-title":"JAMA"},{"issue":"Suppl 1","key":"pone.0275683.ref003","first-page":"S12","article-title":"Review article: Physical and psychological comorbidities associated with irritable bowel syndrome.","volume":"54","author":"MG Shiha","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"pone.0275683.ref004","doi-asserted-by":"crossref","first-page":"755","DOI":"10.18553\/jmcp.2013.19.9.755","article-title":"A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation","volume":"19","author":"D Nellesen","year":"2013","journal-title":"J Manag Care Pharm"},{"issue":"12","key":"pone.0275683.ref005","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1111\/j.1365-2036.2004.02001.x","article-title":"Irritable bowel syndrome\u2014an evidence-based approach to diagnosis","volume":"19","author":"BD Cash","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"pone.0275683.ref006","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/ajg.2014.187","article-title":"American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation","volume":"109","author":"AC Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"pone.0275683.ref007","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/2327-6924.12387","article-title":"Diarrhea-predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations","volume":"28","author":"BE Lacy","year":"2016","journal-title":"J Am Assoc Nurse Pract"},{"issue":"11","key":"pone.0275683.ref008","article-title":"Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome","volume":"6(","author":"BE Lacy","year":"2017","journal-title":"J Clin Med"},{"issue":"11","key":"pone.0275683.ref009","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/gutjnl-2014-307997","article-title":"Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts","volume":"64","author":"WE Ek","year":"2015","journal-title":"Gut"},{"issue":"5","key":"pone.0275683.ref010","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ajg.2014.56","article-title":"Genome-wide association study identifies two novel genomic regions in irritable bowel syndrome","volume":"109","author":"EG Holliday","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"pone.0275683.ref011","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/gast.2001.27995","article-title":"Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology","volume":"121","author":"RL Levy","year":"2001","journal-title":"Gastroenterology"},{"issue":"9","key":"pone.0275683.ref012","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4065\/75.9.907","article-title":"Familial association in adults with functional gastrointestinal disorders","volume":"75","author":"GR Locke","year":"2000","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"pone.0275683.ref013","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/1756283X16633050","article-title":"New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.","volume":"9","author":"AE Foxx-Orenstein","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"issue":"8","key":"pone.0275683.ref014","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1572-0241.1998.440_j.x","article-title":"Evidence of a genetic contribution to functional bowel disorder","volume":"93","author":"A Morris-Yates","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"pone.0275683.ref015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1365-2036.2002.01254.x","article-title":"Extra-intestinal manifestations associated with irritable bowel syndrome: a twin study","volume":"16","author":"P Svedberg","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"pone.0275683.ref016","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1136\/gut.2006.097287","article-title":"Irritable bowel syndrome in twins: genes and environment","volume":"55","author":"MB Bengtson","year":"2006","journal-title":"Gut"},{"issue":"11","key":"pone.0275683.ref017","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2036.2007.03326.x","article-title":"Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study","volume":"25","author":"A Lembo","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"pone.0275683.ref018","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.gtc.2010.12.011","article-title":"The role of genetics in IBS.","volume":"40","author":"YA Saito","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"issue":"10","key":"pone.0275683.ref019","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1007\/s10620-012-2319-9","article-title":"The role of 5-HTT LPR and GNbeta3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS).","volume":"57","author":"YA Saito","year":"2012","journal-title":"Dig Dis Sci"},{"issue":"1","key":"pone.0275683.ref020","doi-asserted-by":"crossref","first-page":"G13","DOI":"10.1152\/ajpgi.00294.2013","article-title":"Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit","volume":"306","author":"M Camilleri","year":"2014","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"pone.0275683.ref021","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/ajg.2013.304","article-title":"Identification of a functional TPH1 polymorphism associated with irritable bowel syndrome bowel habit subtypes","volume":"108","author":"H Grasberger","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"pone.0275683.ref022","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1136\/gutjnl-2013-304570","article-title":"Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome","volume":"63","author":"MM Wouters","year":"2014","journal-title":"Gut"},{"issue":"40","key":"pone.0275683.ref023","doi-asserted-by":"crossref","first-page":"11371","DOI":"10.3748\/wjg.v21.i40.11371","article-title":"Role of environmental pollution in irritable bowel syndrome","volume":"21","author":"M Marynowski","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"2","key":"pone.0275683.ref024","doi-asserted-by":"crossref","first-page":"241","DOI":"10.5056\/jnm18135","article-title":"Is Long-term Ambient Air Pollutant Exposure a Risk Factor for Irritable Bowel Syndrome in Children? A 12-year Longitudinal Cohort Study","volume":"25","author":"TK Tan","year":"2019","journal-title":"J Neurogastroenterol Motil."},{"issue":"4","key":"pone.0275683.ref025","doi-asserted-by":"crossref","first-page":"e62220","DOI":"10.1371\/journal.pone.0062220","article-title":"Environmental particulate matter induces murine intestinal inflammatory responses and alters the gut microbiome","volume":"8","author":"L Kish","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"pone.0275683.ref026","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1289\/ehp.1306534","article-title":"Exercise attenuates PCB-induced changes in the mouse gut microbiome","volume":"121","author":"JJ Choi","year":"2013","journal-title":"Environ Health Perspect"},{"issue":"5","key":"pone.0275683.ref027","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.pharep.2014.04.005","article-title":"Current overview of extrinsic and intrinsic factors in etiology and progression of inflammatory bowel diseases","volume":"66","author":"M Sobczak","year":"2014","journal-title":"Pharmacol Rep"},{"key":"pone.0275683.ref028","article-title":"Predictors of abdominal pain severity in patients with constipation-prevalent irritable bowel syndrome","author":"S Rurgo","year":"2022","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"1","key":"pone.0275683.ref029","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/PSY.0000000000000010","article-title":"Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis","volume":"76","author":"N Afari","year":"2014","journal-title":"Psychosom Med"},{"issue":"4","key":"pone.0275683.ref030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cgh.2011.12.018","article-title":"Association between early adverse life events and irritable bowel syndrome","volume":"10","author":"K Bradford","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"pone.0275683.ref031","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1572-0241.2007.01722.x","article-title":"Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review","volume":"103","author":"DK Chitkara","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"pone.0275683.ref032","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/ajg.2011.201","article-title":"Severity in irritable bowel syndrome: a Rome Foundation Working Team report","volume":"106","author":"DA Drossman","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"pone.0275683.ref033","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/nmo.12353","article-title":"A case-control study of childhood trauma in the development of irritable bowel syndrome","volume":"26","author":"M Halland","year":"2014","journal-title":"Neurogastroenterol Motil"},{"issue":"3","key":"pone.0275683.ref034","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jpsychores.2014.11.021","article-title":"Family history of mental illness or alcohol abuse and the irritable bowel syndrome","volume":"78","author":"JR Knight","year":"2015","journal-title":"J Psychosom Res"},{"issue":"9","key":"pone.0275683.ref035","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1136\/gutjnl-2011-300474","article-title":"The brain\u2014gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study","volume":"61","author":"NA Koloski","year":"2012","journal-title":"Gut"},{"issue":"1","key":"pone.0275683.ref036","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cgh.2011.08.015","article-title":"Diagnosis, comorbidities, and management of irritable bowel syndrome in patients in a large health maintenance organization","volume":"10","author":"U Ladabaum","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"pone.0275683.ref037","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/jgh.12704","article-title":"Irritable bowel syndrome: a comparison of subtypes","volume":"30","author":"NG Rey de Castro","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"pone.0275683.ref038","doi-asserted-by":"crossref","first-page":"104033","DOI":"10.1016\/j.brat.2022.104033","article-title":"Cognitive flexibility improves in cognitive behavioral therapy for irritable bowel syndrome but not nonspecific education\/support","volume":"154","author":"JM Lackner","year":"2022","journal-title":"Behav Res Ther"},{"issue":"5","key":"pone.0275683.ref039","doi-asserted-by":"crossref","first-page":"G799","DOI":"10.1152\/ajpgi.00154.2011","article-title":"Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome","volume":"301","author":"IM Carroll","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"2","key":"pone.0275683.ref040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s10620-009-0934-x","article-title":"A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome","volume":"55","author":"C Codling","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"3","key":"pone.0275683.ref041","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/1574-6941.12184","article-title":"Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome","volume":"86","author":"A Durb\u00e1n","year":"2013","journal-title":"FEMS Microbiol Ecol"},{"issue":"2","key":"pone.0275683.ref042","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1758-2229.2012.00327.x","article-title":"Structural alterations of faecal and mucosa-associated bacterial communities in irritable bowel syndrome","volume":"4","author":"A Durb\u00e1n","year":"2012","journal-title":"Environ Microbiol Rep"},{"issue":"9","key":"pone.0275683.ref043","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1111\/1462-2920.14271","article-title":"Fecal Clostridiales distribution and short-chain fatty acids reflect bowel habits in irritable bowel syndrome","volume":"20","author":"G Gargari","year":"2018","journal-title":"Environ Microbiol"},{"issue":"40","key":"pone.0275683.ref044","doi-asserted-by":"crossref","first-page":"11353","DOI":"10.3748\/wjg.v21.i40.11353","article-title":"Genetic epidemiology of irritable bowel syndrome","volume":"21","author":"J Makker","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"pone.0275683.ref045","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/MED.0b013e32831e9c8e","article-title":"Serotonin in the gastrointestinal tract","volume":"16","author":"M. Camilleri","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"5","key":"pone.0275683.ref046","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1053\/j.gastro.2020.10.066","article-title":"The Microbiota-Gut-Brain Axis: From Motility to Mood","volume":"160","author":"KG Margolis","year":"2021","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0275683.ref047","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/MED.0b013e32835bc703","article-title":"5-Hydroxytryptamine (serotonin) in the gastrointestinal tract","volume":"20","author":"MD Gershon","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"1","key":"pone.0275683.ref048","first-page":"1","article-title":"Enterochromaffin cells in macrophages in ulcerative colitis and irritable colon","volume":"8","author":"A Ahonen","year":"1976","journal-title":"Ann Clin Res"},{"issue":"3","key":"pone.0275683.ref049","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/00365527709180942","article-title":"Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon","volume":"12","author":"K Ky\u00f6sola","year":"1977","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"pone.0275683.ref050","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1053\/j.gastro.2004.03.013","article-title":"Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome","volume":"126","author":"MD Coates","year":"2004","journal-title":"Gastroenterology"},{"issue":"9","key":"pone.0275683.ref051","doi-asserted-by":"crossref","first-page":"G1053","DOI":"10.1152\/ajpgi.00153.2011","article-title":"SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine","volume":"302","author":"AP Kerckhoffs","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"pone.0275683.ref052","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S1542-3565(04)00726-8","article-title":"Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome","volume":"3","author":"SP Dunlop","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"pone.0275683.ref053","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/ajg.2014.148","article-title":"Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta-analysis","volume":"109","author":"AC Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"pone.0275683.ref054","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1096\/fj.13-246546","article-title":"Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism","volume":"28","author":"RP Patrick","year":"2014","journal-title":"FASEB J"},{"issue":"9","key":"pone.0275683.ref055","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1096\/fj.14-269811","article-title":"1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: implication for behavioral influences of vitamin D","volume":"29","author":"I Kaneko","year":"2015","journal-title":"FASEB J"},{"key":"pone.0275683.ref056","article-title":"Chapter 8\u2014Nuclear Vitamin D Receptor: Natural Ligands, Molecular Structure\u2013Function, and Transcriptional Control of Vital Genes","author":"MR Haussler","year":"2011"},{"issue":"8","key":"pone.0275683.ref057","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00406-014-0502-z","article-title":"Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis","volume":"264","author":"G Fond","year":"2014","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"11","key":"pone.0275683.ref058","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4065\/mcp.2011.0208","article-title":"Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study","volume":"86","author":"MT Hoang","year":"2011","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"pone.0275683.ref059","doi-asserted-by":"crossref","first-page":"e0172183","DOI":"10.1371\/journal.pone.0172183","article-title":"Vitamin D status in pediatric irritable bowel syndrome.","volume":"12","author":"BU Nwosu","year":"2017","journal-title":"PLoS One"},{"issue":"11","key":"pone.0275683.ref060","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1177\/1535370214523890","article-title":"Vitamin D, immune regulation, the microbiota, and inflammatory bowel disease","volume":"239","author":"MT Cantorna","year":"2014","journal-title":"Exp Biol Med (Maywood)."},{"issue":"4","key":"pone.0275683.ref061","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/apt.12188","article-title":"Letter: vitamin D supplementation and the irritable bowel syndrome","volume":"37","author":"F Karaahmet","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"pone.0275683.ref062","first-page":"2012","article-title":"Vitamin D3 as a novel treatment for irritable bowel syndrome: single case leads to critical analysis of patient-centred data","author":"EF Sprake","year":"2012","journal-title":"BMJ Case Rep"},{"issue":"1","key":"pone.0275683.ref063","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/gut.42.1.42","article-title":"Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study","volume":"42","author":"CP Bearcroft","year":"1998","journal-title":"Gut"},{"issue":"1","key":"pone.0275683.ref064","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2005.09.031","article-title":"Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome","volume":"130","author":"W Atkinson","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"pone.0275683.ref065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2006.11.020","article-title":"Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome","volume":"132","author":"M Camilleri","year":"2007","journal-title":"Gastroenterology"},{"issue":"10","key":"pone.0275683.ref066","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1136\/gut.2003.035451","article-title":"Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women","volume":"53","author":"A Yeo","year":"2004","journal-title":"Gut"},{"issue":"8","key":"pone.0275683.ref067","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1371\/journal.pmed.0020199","article-title":"Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays","volume":"2","author":"CM Costello","year":"2005","journal-title":"PLoS Med"},{"issue":"1","key":"pone.0275683.ref068","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5056\/jnm17021","article-title":"Gene Expression Profiling and Assessment of Vitamin D and Serotonin Pathway Variations in Patients With Irritable Bowel Syndrome.","volume":"24","author":"CM Dussik","year":"2018","journal-title":"J Neurogastroenterol Motil"},{"issue":"7","key":"pone.0275683.ref069","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"ME Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"pone.0275683.ref070","first-page":"30","article-title":"Modulation of Serotonin Synthesis, Reuptake, and Degradation by 1,25-Dihydroxyvitamin D: Potential Relevance for Neuropsychiatric Disorders","author":"MS Sabir","year":"2016","journal-title":"The FASEB Journal"},{"key":"pone.0275683.ref071","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/ctg.2012.8","article-title":"Serotonin and GI Disorders: An Update on Clinical and Experimental Studies","volume":"3","author":"M Manocha","year":"2012","journal-title":"Clin Transl Gastroenterol"},{"issue":"2","key":"pone.0275683.ref072","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cgh.2007.11.012","article-title":"Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome","volume":"6","author":"J Aerssens","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"pone.0275683.ref073","doi-asserted-by":"crossref","first-page":"G140","DOI":"10.1152\/ajpgi.00288.2017","article-title":"Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation","volume":"315","author":"EJ Videlock","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"pone.0275683.ref074","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1053\/j.gastro.2006.11.002","article-title":"The serotonin signaling system: from basic understanding to drug development for functional GI disorders","volume":"132","author":"MD Gershon","year":"2007","journal-title":"Gastroenterology"},{"issue":"3","key":"pone.0275683.ref075","doi-asserted-by":"crossref","first-page":"e0172846","DOI":"10.1371\/journal.pone.0172846","article-title":"Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: A systematic review and meta-analysis of randomized controlled trials","volume":"12","author":"Y Zheng","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"pone.0275683.ref076","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1365-2036.2007.03453.x","article-title":"Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome","volume":"26","author":"LA Van Kerkhoven","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"pone.0275683.ref077","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/apt.12222","article-title":"Letter: serotonin transporter gene polymorphisms and the irritable bowel syndrome","volume":"37","author":"C Dai","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"pone.0275683.ref078","doi-asserted-by":"crossref","first-page":"e75567","DOI":"10.1371\/journal.pone.0075567","article-title":"A serotonin transporter gene (SLC6A4) polymorphism is associated with reduced risk of irritable bowel syndrome in American and Asian population: a meta-analysis","volume":"8","author":"MY Areeshi","year":"2013","journal-title":"PLoS One"},{"key":"pone.0275683.ref079","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-230X-14-23","article-title":"The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies","volume":"14","author":"ZF Zhang","year":"2014","journal-title":"BMC Gastroenterol"},{"issue":"16","key":"pone.0275683.ref080","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1523\/JNEUROSCI.21-16-06348.2001","article-title":"Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter: Abnormal intestinal motility and the expression of cation transporters","volume":"21","author":"JJ Chen","year":"2001","journal-title":"J Neurosci"},{"issue":"Suppl 7","key":"pone.0275683.ref081","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2004.02180.x","article-title":"Review article: serotonin receptors and transporters\u2014roles in normal and abnormal gastrointestinal motility.","volume":"20","author":"MD Gershon","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"pone.0275683.ref082","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1073\/pnas.0805323106","article-title":"TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells","volume":"106","author":"K Nozawa","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0275683.ref083","doi-asserted-by":"crossref","first-page":"e000052","DOI":"10.1136\/bmjgast-2015-000052","article-title":"Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial","volume":"2","author":"S Tazzyman","year":"2015","journal-title":"BMJ Open Gastroenterol"},{"issue":"10","key":"pone.0275683.ref084","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/gut.2003.035568","article-title":"Pharmacology of serotonin: what a clinician should know","volume":"53","author":"F. De Ponti","year":"2004","journal-title":"Gut"},{"key":"pone.0275683.ref085","article-title":"Vitamin D supplementation in people with IBS has no effect on symptom severity and quality of life: results of a randomised controlled trial.","author":"CE Williams","year":"2021","journal-title":"Eur J Nutr"},{"issue":"2","key":"pone.0275683.ref086","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/med.21752","article-title":"Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: A therapeutic target to control intestinal inflammation","volume":"41","author":"J Zhang","year":"2021","journal-title":"Med Res Rev"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0275683","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T18:19:17Z","timestamp":1666289957000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0275683"}},"subtitle":[],"editor":[{"given":"Michal","family":"Zmijewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":86,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0275683","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]}}}